Join us for an exciting webinar offering a fresh look at the future of women’s health! Discover the latest advancements in HPV screening, including how each high-risk HPV genotype plays a key role in cervical cancer screening programs. Plus, learn about the impact of different HPV genotypes on women’s health and why risk-based prevention strategies are so important. #Seegene #Webinar #WomensHealth #HPV #HPVscreening #CervicalCancer
Chi siamo
[INTRODUCING OUR COMPANY] The people of Seegene are on a purposeful mission to improve the world we live in. We aim to improve the quality of life for everyone globally by bringing molecular diagnostics to the masses. Molecular diagnostics is the most effective method to accurately diagnose ailments and is also the best way to diagnose them early which is when you can make the most difference in the recovery treatment. With industry-leading IP in molecular diagnostics reagent assays, we are dedicated to leveraging our unique technologies to increase our product portfolio, expand our market coverage, and lowering the total cost to serve our customers so that molecular diagnostics become a part of the fabric of everyone’s life and thus, improving the quality of life for everyone in the world. [OUR HISTORY AND OUR FUTURE] Since our founding in 2000, we have been steadfastly focused on molecular diagnostics. Currently, our product portfolio consists of over 250 molecular diagnostics reagent kits as well as a wide range of instruments and consumables that are sold globally. Testament to our expertise, when the pandemic started, Seegene was one of the first companies in the world to provide testing kits that were crucial in the fight against COVID. Today, we are a company with revenue of over $1 billion dollars and 65% gross margins. With 8 overseas entities, we generate a majority of our revenue outside of Korea. In keeping with our spirit of innovation and making a difference in the world, there are many exciting innovations being worked on at Seegene which will make it easier for the world to access the benefits of molecular diagnostics. We are transforming our business from a discrete reagent assay and instruments business to a platform business that will create new markets for molecular diagnostics and improve the quality of life for everyone. We hope that you will join us in our mission to make a meaningful difference in the world.
- Sito Web
-
https://www.seegene.com/
Link esterno per Seegene Inc.
- Settore
- Ricerca biotecnologica
- Dimensioni dell’azienda
- 1001 - 5000 dipendenti
- Sede principale
- 서울
- Tipo
- Società quotata
- Data di fondazione
- 2000
- Settori di competenza
- in-vitro diagnostics (IVD), companion diagnostics, molecular diagnostic (MoDx), nucleic acid testing (NAT), infectious disease detection, respiratory pathogen detection e sexually transmitted disease (STD) detection
Località
Dipendenti presso Seegene Inc.
Aggiornamenti
-
October 29 is #WorldPsoriasisDay, a day to raise awareness of those suffering from the skin condition that causes scale-like patches of skin. This year, we gather together in the theme of #PsoriaticDiseaseAndFamily and recognize that living with the psoriatic disease may be tough for both the person affected and their family members. Join #Seegene in acknowledging these challenges and show our support for every individual and family impacted by #PsoriaticDisease.
-
-
🤝 At the first-ever executive #roundtable in London, (주)씨젠, 마이크로소프트, and Springer Nature came together to discuss the future of healthcare and accelerate our technology-sharing initiative. The event highlighted AI-powered advancements in diagnostic technology and the creation of a global ecosystem for collaboration. By combining Seegene’s PCR #diagnostics, Microsoft’s #AI technology, and Springer Nature’s vast scientific #network, we are working towards a world free from diseases. 🔗Read more here: https://bit.ly/4e3xsyy #Seegene #Microsoft #SpringerNature
-
-
Excited to be part of an event bridging Korea and Europe. Together, we’re shaping a better future through global collaboration and innovation! #Seegene #Düsseldorf #SeegeneGermany #ZukunftGestalten
Zurück von einer Delegationsreise der Landeshauptstadt Düsseldorf nach Korea mit vielen Eindrücken und guten Nachrichten im Gepäck! 🌏 Die Gespräche und Einblicke bei den innovativen Unternehmen in Seoul waren beeindruckend: 💡 Seegene Germany GmbH, Spezialist für PCR-Molekulardiagnostik, hat seit 2017 seinen Sitz in Düsseldorf und plant ihn nächstem Jahr zur Europazentrale auszubauen. Besonders berührt hat mich die Vision von Dr. Jong-Yoon Chun, Gründer von Seegene: „Eine Welt ohne Krankheiten“ 💡AIMMO, entwickelt Anwendungen für KI-gestützte Bildverarbeitung, betreibt seit September 2023 ein Büro in Düsseldorf und wird künftig auch mit dem Mercedes Benz Sprinter Werk zusammenarbeiten, um den europäischen Markt zu bedienen. 💡Mischkonzern HD Hyundai ist seit 2023 mit einem europäischen Forschungszentrum in Düsseldorf vertreten und konzentriert sich u.a. auf nachhaltige Antriebstechnik 💡Doosan Robotics entwickelt Cobots, die Menschen bei anspruchsvollen Aufgaben unterstützen und hat im August 2024 seine Europazentrale in Düsseldorf eröffnet Dank unseres neuen Korea-Desk der Wirtschaftsförderung Düsseldorf sind wir bestens aufgestellt, um diese und weitere strategische Partnerschaften auszubauen. Dazu gehört auch gemeinsam mit Wolfram Diener und der MEDICA - Leading International Trade Fair 2024 der Messe Düsseldorf GmbH ein starkes Netzwerk zu schaffen, das der gesamten Branche zugutekommt. Anlässlich der 20-jährigen Städtepartnerschaft besuchten wir zum Abschluss der Reise noch unsere chinesische Partnerstadt Chongqing. #Düsseldorf #Innovation #StartUps #Investitionen #Seegene #AIMMO #HDHyundai #DoosanRobotics #ZukunftGestalten
-
-
-
-
-
2
-
-
Do you know the key risk factors for HPV infection? Check out Seegene’s blog for essential insights on HPV infection and how effective screening programs can protect your health: https://bit.ly/401R9DM #Seegene #HPV #PreventiveCare #CervicalCancer #Screening
-
-
We're excited to share an article produced in partnership with Springer Nature on #PCR technology that is revolutionizing healthcare with a faster & more accurate diagnosis of multiple pathogens. With advancements in #automation and #multiplexing, PCR will be more accessible, precise, and cost-effective. Read more about the latest breakthroughs in PCR and their potential impact: 👉 https://bit.ly/4eVKhMo #Seegene #SpringerNature #MultiplexPCR #MolecularDiagnostics #brandedarticle
-
On October 5, the world unites to recognize #WorldMeningitisDay. Meningitis can affect anyone, anytime, and it can progress rapidly. Without prompt treatment, it can be fatal within hours or lead to long-term health complications and suffering. However, with vaccination and timely action based on syndromic testing for symptoms, we can defeat meningitis. Join the fight to #DefeatMeningitis. #Seegene #Meningitis #AWorldFreeFromDiseases
-
-
Today’s the day! Don’t miss out on the exciting webinar we prepared in partnership with #Nature: "How Molecular Diagnostics Can Make an Impact on Public Health." Join Zoltan Fehervari, Senior Editor at Nature, and Ulrich Eigner, Head of Studies on Infection Diagnostics at Laboratory Limbach, as they share invaluable insights into infectious diseases and the impact of innovative diagnostics. ⌛ If you haven’t signed up yet, there’s still time—plus, registering gives you access to on-demand viewing after the live event! 🔗 Register now: https://bit.ly/4eA5TO9 ▶ Date & time: October 3, 2024 | 8:00 PDT | 11:00 EDT | 16:00 BST | 17:00 CEST ▶ Presenters: Zoltan Fehervari & Ulrich Eigner #Seegene #SpringerNature #MolecularDiagnostics #MDxImpactGrants #NatureAwards
-
-
✨October is #HealthyLungMonth! Proper lung care is essential to overall health. Regular check-ups and early diagnosis of #pneumonia can help protect your lungs and keep you healthy. Let’s protect our lung health together! 🫁 #Seegene #LungHealth
-
-
💡 Discover how molecular diagnostics can make an impact on public health on October 3! In this webcast, Zoltan Fehervari, Senior Editor, Nature, will explore the outlook on infectious diseases now and on the horizon, and Ulrich Eigner, head of Studies on Infection Diagnostics at the Laboratory Limbach, will share his experience working with Seegene as a grantee of the Open Innovation Program, the predecessor to the MDx Impact Grants. You don't want to miss out on this! Register here: https://bit.ly/4eA5TO9 *Register now to also gain access to on-demand viewing after the live event. 🖥 Webcast details ▶ Subject: How Molecular Diagnostics Can Make an Impact on Public Health ▶ Date & time: October 3, 2024 | 8:00 PDT | 11:00 EDT | 16:00 BST | 17:00 CEST ▶ Presenters: Zoltan Fehervari, Ulrich Eigner #Seegene #MolecularDiagnostics #OpenInnovationProgram #MDxImpactGrants